BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:NextCure\, Inc. (NXTC) investor events
X-WR-CALNAME:NextCure\, Inc. (NXTC) investor events
DESCRIPTION:Earnings calls and investor events for NextCure\, Inc. (NXTC)\,
  from Equibles.
X-WR-CALDESC:Earnings calls and investor events for NextCure\, Inc. (NXTC)\
 , from Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:ac6fe282-d75f-464f-9f3e-9f1748289524@equibles.com
DTSTAMP:20260617T191130Z
DTSTART;VALUE=DATE:20251105
DTEND;VALUE=DATE:20251106
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:NextCure\, Inc. (NXTC) Earnings Call\, FY2025 Q3
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:a11a8332-da67-405c-b24b-1962c1954770@equibles.com
DTSTAMP:20260617T190858Z
DTSTART;VALUE=DATE:20260123
DTEND;VALUE=DATE:20260124
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:NextCure\, Inc. (NXTC) Earnings Call\, FY2025 Q4
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:426bb535-5216-465d-9e03-27e1f0c45020@equibles.com
DTSTAMP:20260617T191048Z
DTSTART;VALUE=DATE:20260507
DTEND;VALUE=DATE:20260508
SEQUENCE:0
STATUS:CANCELLED
TRANSP:TRANSPARENT
SUMMARY:NextCure\, Inc. (NXTC) Earnings Call\, FY2026 Q1
DESCRIPTION:No call was held: the company published its results without one
 .
END:VEVENT
BEGIN:VEVENT
UID:c81b46c9-deff-4f92-b36a-180584d09420@equibles.com
DTSTAMP:20260624T233124Z
DTSTART;VALUE=DATE:20260602
DTEND;VALUE=DATE:20260603
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:NextCure\, Inc. (NXTC) Capital Markets Day: Virtual KOL Event to Di
 scuss ASCO 2026 Presentation of SIM0505 Phase 1 Dose Escalation Data in Gy
 necologic Cancers
DESCRIPTION:Virtual KOL Event to Discuss ASCO 2026 Presentation of SIM0505 
 Phase 1 Dose Escalation Data in Gynecologic Cancers\nThe start time has no
 t been announced.\nWebcast: https://ir.nextcure.com/events/event-details/v
 irtual-kol-event-discuss-asco-2026-presentation-sim0505-phase-1-dose
END:VEVENT
END:VCALENDAR